loadpatents
name:-0.062114953994751
name:-0.017380952835083
name:-0.019717931747437
Kuchroo; Vijay K. Patent Filings

Kuchroo; Vijay K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kuchroo; Vijay K..The latest application filed is for "modulation of type 2 immunity by targeting clec-2 signaling".

Company Profile
21.21.61
  • Kuchroo; Vijay K. - Boston MA
  • KUCHROO; Vijay K. - Newton MA
  • Kuchroo; Vijay K. - Chestnut Hill MA
  • Kuchroo; Vijay K. - Newton Center MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
T cell balance gene expression, compositions of matters and methods of use thereof
Grant 11,427,869 - Regev , et al. August 30, 2
2022-08-30
Modulation Of Type 2 Immunity By Targeting Clec-2 Signaling
App 20220152148 - Burkett; Patrick R. ;   et al.
2022-05-19
Targeting Regulatory B Cells And Their Regulators For Cancer Immunotherapy
App 20220144950 - KUCHROO; Vijay K. ;   et al.
2022-05-12
Compositions And Methods For Modulating Metabolic Regulators Of T Cell Pathogenicity
App 20220142948 - Regev; Aviv ;   et al.
2022-05-12
Methods And Compositions For The Modulation Of Opioid Signaling In The Tumor Microenvironment
App 20220105135 - Singer; Meromit ;   et al.
2022-04-07
Compositions And Methods For Modulating Cgrp Signaling To Regulate Innate Lymphoid Cell Inflammatory Responses
App 20210386829 - Wallrapp; Antonia ;   et al.
2021-12-16
Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1
Grant 11,186,825 - Regev , et al. November 30, 2
2021-11-30
Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3
Grant 11,180,730 - Regev , et al. November 23, 2
2021-11-23
Bi-specific Antibodies Against Tim-3 And Pd-1 For Immunotherapy In Chronic Immune Conditions
App 20210332130 - KUCHROO; Vijay K. ;   et al.
2021-10-28
Method Of Treating Autoimmune Disease With Lymphocyte Antigen Cd5-like (cd5l) Protein
App 20210317186 - Kuchroo; Vijay K. ;   et al.
2021-10-14
Methods And Compositions For Modulating Immune Responses And Lymphocyte Activity
App 20210263012 - Anderson; Ana C. ;   et al.
2021-08-26
Lymphocyte Antigen Cd5-like (cd5l) Monomer, Homodimer, And Interleukin 12b (p40) Heterodimer Agonists And Methods Of Use Thereof
App 20210139601 - Kuchroo; Vijay K. ;   et al.
2021-05-13
Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein
Grant 11,001,622 - Kuchroo , et al. May 11, 2
2021-05-11
Methods And Compositions For Modulating Suppression Of Lymphocyte Activity
App 20210130776 - Anderson; Ana Carrizosa ;   et al.
2021-05-06
Pan-cancer T Cell Exhaustion Genes
App 20210130438 - Jerby-Arnon; Livnat ;   et al.
2021-05-06
Methods And Compositions For Regulating Innate Lymphoid Cell Inflammatory Responses
App 20210121530 - Wallrapp; Antonia ;   et al.
2021-04-29
Methods And Compositions For The Modulation Of Cell Interactions And Signaling In The Tumor Microenvironment
App 20210102168 - Singer; Meromit ;   et al.
2021-04-08
Compositions And Methods For Modulating And Detecting Tissue Specific Th17 Cell Pathogenicity
App 20210102166 - Singer; Meromit ;   et al.
2021-04-08
Methods And Compositions For Enhancing Anti-tumor Immunity By Targeting Steroidogenesis
App 20210100774 - Anderson; Ana Carrizosa ;   et al.
2021-04-08
Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions
Grant 10,934,352 - Kuchroo , et al. March 2, 2
2021-03-02
Methods For Predicting Outcomes And Treating Colorectal Cancer Using A Cell Atlas
App 20210047694 - Regev; Aviv ;   et al.
2021-02-18
Lymphocyte Antigen Cd5like (cd5l) Monomer, Homodimer, And Interleukin 12b (p40) Heterodimer Antagonists And Methods Of Use There
App 20200157237 - Regev; Aviv ;   et al.
2020-05-21
Methods And Compositions For Modulating Cytotoxic Lymphocyte Activity
App 20200149009 - Regev; Aviv ;   et al.
2020-05-14
Modulation Of The Immune Response
App 20200095284 - BLUMBERG; RICHARD S. ;   et al.
2020-03-26
T Cell Balance Gene Expression, Compositions Of Matters And Methods Of Use Thereof
App 20200081017 - Kuchroo; Vijay K. ;   et al.
2020-03-12
Modulation Of Novel Immune Checkpoint Targets
App 20200016202 - KUCHROO; Vijay K. ;   et al.
2020-01-16
Modulation of the immune response
Grant 10,513,540 - Blumberg , et al. Dec
2019-12-24
Methods And Compositions Targeting Glucocorticoid And Il-27 Signaling For Modulating Immune Responses
App 20190365781 - Anderson; Ana Carrizosa ;   et al.
2019-12-05
Compositions And Methods For Modulating Th-17 And Th-1 Cell Balance
App 20190345446 - Wang; Chao ;   et al.
2019-11-14
Compositions And Methods For Evaluating And Modulating Immune Responses
App 20190262399 - Wang; Chao ;   et al.
2019-08-29
Modulation Of Novel Immune Checkpoint Targets
App 20190255107 - KUCHROO; Vijay K. ;   et al.
2019-08-22
Regulators Of B Cell-mediated Immunosuppression
App 20190225701 - Kuchroo; Vijay K. ;   et al.
2019-07-25
Compositions And Methods For Evaluating And Modulating Immune Responses By Detecting And Targeting Pou2af1
App 20190106678 - Regev; Aviv ;   et al.
2019-04-11
Compositions And Methods For Evaluating And Modulating Immune Responses By Detecting And Targeting Gata3
App 20190106679 - Regev; Aviv ;   et al.
2019-04-11
Compositions And Methods For Evaluating And Modulating Immune Responses By Use Of Immune Cell Gene Signatures
App 20190100801 - Regev; Aviv ;   et al.
2019-04-04
Lymphocyte Antigen Cd5-like (cd5l)-interleukin 12b (p40) Heterodimers In Immunity
App 20180355016 - KUCHROO; Vijay K. ;   et al.
2018-12-13
Methods Related To Tim 3, A Th1-specific Cell Surface Molecule, For Activating Antigen Presenting Cells
App 20180271977 - Kuchroo; Vijay K. ;   et al.
2018-09-27
Methods related to TIM 3, a TH1-specific cell surface molecule, for activating antigen presenting cells
Grant 9,962,440 - Kuchroo , et al. May 8, 2
2018-05-08
Bi-specific Antibodies Against Tim-3 And Pd-1 For Immunotherapy In Chronic Immune Conditions
App 20180051083 - KUCHROO; Vijay K. ;   et al.
2018-02-22
T Cell Balance Gene Expression, Compositions Of Matters And Methods Of Use Thereof
App 20170349950 - Regev; Aviv ;   et al.
2017-12-07
Bi-specific antibodies against Tim-3 and PD-1 for immunotherapy in chronic immune conditions
Grant 9,834,607 - Kuchroo , et al. December 5, 2
2017-12-05
Selective differentiation, identification, and modulation of human TH17 cells
Grant 9,732,320 - Kuchroo , et al. August 15, 2
2017-08-15
Selective Differentiation, Identification, And Modulation Of Human Th17 Cells
App 20170159016 - KUCHROO; Vijay K. ;   et al.
2017-06-08
Methods For Modulating Immune Responses During Chronic Immune Conditions By Targeting Il-27 Induced Pathways
App 20170058026 - Kuchroo; Vijay K. ;   et al.
2017-03-02
Methods For Modulating Immune Responses During Chronic Immune Conditions By Targeting Metallothioneins
App 20160215042 - KUCHROO; Vijay K. ;   et al.
2016-07-28
TIM-3 ligands and methods of modulating immune responses
Grant 9,346,876 - Kuchroo , et al. May 24, 2
2016-05-24
Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
Grant 9,333,256 - Kuchroo , et al. May 10, 2
2016-05-10
Bi-specific Antibodies Against Tim-3 And Pd-1 For Immunotherapy In Chronic Immune Conditions
App 20160002334 - Kuchroo; Vijay K. ;   et al.
2016-01-07
Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions
Grant 9,163,087 - Kuchroo , et al. October 20, 2
2015-10-20
Methods For Modulating Immune Responses During Chronic Immune Conditions By Targeting Il-27 Induced Pathways
App 20150284459 - Kuchroo; Vijay K. ;   et al.
2015-10-08
Modulation Of The Immune Response
App 20150225457 - Blumberg; Richard S. ;   et al.
2015-08-13
Methods Of Modulating Immune Responses By Modulating Tim-1, Tim-2 And Tim-4 Function
App 20150079085 - Kuchroo; Vijay K. ;   et al.
2015-03-19
Selective Differentiation, Identification, And Modulation Of Human Th17 Cells
App 20150050732 - KUCHROO; Vijay K. ;   et al.
2015-02-19
Methods Related To Tim 3, A Th1-specific Cell Surface Molecule, For Activating Antigen Presenting Cells
App 20150044229 - Kuchroo; Vijay K. ;   et al.
2015-02-12
Methods Related To Tim 3, A Th1-specific Cell Surface Molecule, For Activating Antigen Presenting Cells
App 20150044230 - Kuchroo; Vijay K. ;   et al.
2015-02-12
Tim-3 Ligands And Methods Thereof
App 20140348842 - Kuchroo; Vijay K. ;   et al.
2014-11-27
Methods Related To Tim 3, A Th1-specific Cell Surface Molecule, For Activating Antigen Presenting Cells
App 20140242094 - Kuchroo; Vijay K. ;   et al.
2014-08-28
Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells
Grant 8,697,069 - Kuchroo , et al. April 15, 2
2014-04-15
Methods Of Modulating Immune Responses By Modulating Tim-1, Tim-2 And Tim-4 Function
App 20130195895 - Kuchroo; Vijay K. ;   et al.
2013-08-01
Tim-3 Ligands And Methods Thereof
App 20130183688 - Kuchroo; Vijay K. ;   et al.
2013-07-18
Bi-specific Antibodies Against Tim-3 And Pd-1 For Immunotherapy In Chronic Immune Conditions
App 20130156774 - Kuchroo; Vijay K. ;   et al.
2013-06-20
Methods for treating autoimmune disorders, and reagents related thereto
Grant 8,410,053 - Bachovchin , et al. April 2, 2
2013-04-02
Modulation Of Sgk1 Expression In Th17 Cells To Modulate Th17-mediated Immune Responses
App 20130017188 - Kuchroo; Vijay K. ;   et al.
2013-01-17
Compositions And Methods Related To Tim 3, A Th1-specific Cell Surface Molecule
App 20120315286 - Kuchroo; Vijay K. ;   et al.
2012-12-13
Tim-3 ligands and methods thereof
Grant 8,329,660 - Kuchroo , et al. December 11, 2
2012-12-11
Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
App 20120232004 - Bachovchin; William W. ;   et al.
2012-09-13
Compositions and methods related to TIM-3, a TH1-specific cell surface molecule
Grant 8,101,176 - Kuchroo , et al. January 24, 2
2012-01-24
Selective Differentiation, Identification, Amd Modulation Of Human Th17 Cells
App 20110245107 - Kuchroo; Vijay K. ;   et al.
2011-10-06
Methods For Modulating A Population Of Myeloid-derived Suppressor Cells And Uses Thereof
App 20110059106 - Kuchroo; Vijay K. ;   et al.
2011-03-10
Methods Of Modulating Immune Responses By Modulating Tim-1, Tim-2 And Tim-4 Function
App 20110045002 - Kuchroo; Vijay K. ;   et al.
2011-02-24
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
Grant 7,741,271 - Kuchroo , et al. June 22, 2
2010-06-22
Therapeutic Uses Of Tim-3 Modulators
App 20100061992 - Anderson; David E. ;   et al.
2010-03-11
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
App 20050261224 - Kuchroo, Vijay K. ;   et al.
2005-11-24
Tim-3 ligands and methods thereof
App 20050191721 - Kuchroo, Vijay K. ;   et al.
2005-09-01
Methods for treating autoimmune disorders, and reagents related thereto
App 20050070459 - Bachovchin, William W. ;   et al.
2005-03-31
Compositions and methods related to TIM-3, a Th1-specific cell surface molecule
App 20040005322 - Kuchroo, Vijay K. ;   et al.
2004-01-08
Specific antibodies and antibody fragments
Grant 6,207,156 - Kuchroo , et al. March 27, 2
2001-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed